Malawi vs Paraguay: Cause of death, by non-communicable diseases, ages 15-59
Malawi
38.8%
in 2021
Paraguay
37.8%
in 2021
Malawi rank
158th
Paraguay rank
161st
Cause of death, by non-communicable diseases, ages 15-59 over time
- Malawi
- Paraguay
How they compare
Malawi currently reports 38.8% against 37.8% in Paraguay, a difference of 1.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Paraguay ahead.
Malawi ranks 158th and Paraguay ranks 161st of 185 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malawi | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.1% | 56.1% | 41.0% | Paraguay |
| 2010s | 33.8% | 60.5% | 26.7% | Paraguay |
| 2020s | 40.1% | 47.5% | 7.4% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Malawi or Paraguay?
- Malawi, at 38.8% against 37.8% in Paraguay as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Malawi and Paraguay?
- 1.0%, with Malawi ahead.
- How many years of comparable data are there for Malawi and Paraguay?
- 6 years are reported by both, from 2000 to 2021.
- How do Malawi and Paraguay rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Malawi ranks 158th and Paraguay ranks 161st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.